Correlation Between Ubs Money and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Ubs Money and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ubs Money and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ubs Money Series and Biotechnology Fund Class, you can compare the effects of market volatilities on Ubs Money and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ubs Money with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ubs Money and Biotechnology Fund.
Diversification Opportunities for Ubs Money and Biotechnology Fund
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ubs and Biotechnology is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ubs Money Series and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Ubs Money is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ubs Money Series are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Ubs Money i.e., Ubs Money and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Ubs Money and Biotechnology Fund
If you would invest 100.00 in Ubs Money Series on October 24, 2024 and sell it today you would earn a total of 0.00 from holding Ubs Money Series or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ubs Money Series vs. Biotechnology Fund Class
Performance |
Timeline |
Ubs Money Series |
Biotechnology Fund Class |
Ubs Money and Biotechnology Fund Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ubs Money and Biotechnology Fund
The main advantage of trading using opposite Ubs Money and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ubs Money position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.Ubs Money vs. Hunter Small Cap | Ubs Money vs. Needham Aggressive Growth | Ubs Money vs. L Abbett Growth | Ubs Money vs. Small Pany Growth |
Biotechnology Fund vs. Nuveen Strategic Municipal | Biotechnology Fund vs. Blrc Sgy Mnp | Biotechnology Fund vs. Bbh Intermediate Municipal | Biotechnology Fund vs. Lord Abbett Intermediate |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |